Table 2.
Predictors for composite outcome in the entire cohort
| Variable | Model 1 | Model 2 | ||||||
|---|---|---|---|---|---|---|---|---|
| HR | 95% CI | p-value | HR | 95% CI | p-value | |||
| BMI | 0.9378 | 0.9116–0.9647 | <0.0001 | 0.9400 | 0.9131–0.9677 | <0.0001 | ||
| Hyperlipidemia | 0.5801 | 0.4527–0.7433 | <0.0001 | 0.5741 | 0.4478–0.7361 | <0.0001 | ||
| TG | 0.8784 | 0.7794–0.9900 | 0.0337 | 0.8791 | 0.7796–0.9913 | 0.0355 | ||
| HDL-C | 0.6389 | 0.4546–0.8979 | 0.0099 | 0.6444 | 0.4586–0.9053 | 0.0113 | ||
| GFR | 0.9807 | 0.9769–0.9846 | <0.0001 | |||||
| Aspirin | 0.7233 | 0.5372–0.9739 | 0.0328 | 0.6852 | 0.5159–0.9101 | 0.0090 | ||
| CHADS2 | 2.1848 | 2.0075–2.3777 | <0.0001 | |||||
| R2CHADS2 | 1.9299 | 1.8288 | 2.0365 | <0.0001 | ||||
Notes: Cox regression multivariate: model 1 was adjusted for sex, smoking, BMI, hyperlipidemia, GFR, TC, TG, LDL-C, HDL-C, and medication at discharge, while model 2 was adjusted for the aforementioned covariates except GFR. CHADS2, congestive heart failure, hypertension, age, diabetes, and stroke/transient ischemic attack; R2CHADS2, renal dysfunction, congestive heart failure, hypertension, age, diabetes, and stroke/transient ischemic attack.
Abbreviations: BMI, body mass index; GFR, glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; HR, hazard ratio; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides.